The 2011 Hedge Fund 100 March 2, 2011 Related Articles With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma Stephen Taub How Hiddenite, a Young Long‑Short Fund, Delivered a Second Straight Triple‑Digit Year Stephen Taub II Communities on Alternative Investments Sponsored by Fidelity Investments